The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Abstract

Background Pancreatitis is a critical public health problem, and the burden of pancreatitis is increasing. We report the rates and trends of the prevalence, incidence, and years lived with disability (YLDs) for pancreatitis at the global, regional, and national levels in 195 countries and territories from 1990 to 2017, stratified by sex, age, and sociodemographic index (SDI). Methods Data on pancreatitis were available from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017. Numbers and age-standardized prevalence, incidence, and YLDs’ rates per 100,000 population were estimated through a systematic analysis of modeled data from the 2017 GBD study. Both acute and chronic pancreatitis are being modeled separately in the GBD 2017; however, our data show acute and chronic pancreatitis together. Estimates were reported with uncertainty intervals (UIs). Results Globally, in 2017, the age-standardized rates were 76.2 (95% UIs 68.9 to 83.4), 20.6 (19.2 to 22.1), and 4.5 (2.3 to 7.6) per 100,000 population for the point prevalence, incidence, and YLDs, respectively. From 1990 to 2017, the percent changes in the age-standardized prevalence and YLDs rates increased, whereas the age-standardized incidence rate decreased. The global prevalence increased with age up to 60–64 years and 44–49 years in females and males, respectively, and then decreased, with no significant difference between females and males. The global prevalence rate increased with age, peaking in the 95+ age group, with no difference between sexes. Generally, positive correlation between age-standardized YLDs and SDIs at the regional and national levels was observed. Slovakia (297.7 [273.4 to 325.3]), Belgium (274.3 [242.6 to 306.5]), and Poland (266.7 [248.2 to 284.4]) had the highest age-standardized prevalence rates in 2017. Taiwan (Province of China) (104.2% [94.8 to 115.2%]), Maldives (72.4% [66.5 to 79.2%]), and Iceland (64.8% [57.2 to 72.9%]) had the largest increases in age-standardized prevalence rates from 1990 to 2017. Conclusions Pancreatitis is a major public health issue worldwide. The age-standardized prevalence and YLDs rates increased, but the age-standardized incidence rate decreased from 1990 to 2017. Improving the quality of pancreatitis health data in all regions and countries is strongly recommended for better monitoring the burden of pancreatitis.

Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study

“…Acute pancreatitis remains a prevalent source of hospitalization and morbidity worldwide ( 17 ). Drug-induced pancreatitis, although a less common etiology, is being increasingly recognized for its importance because of the expanding number of traditional and homeopathic medications available and the increasing prevalence of chronic illnesses requiring long-term pharmacologic therapy ( 18 ).…”

Pancreatogenic Diabetes: Triggering Effects of Alcohol and HIV

“…Meanwhile, the global prevalence of pancreatitis has continued to increase. In 1990, the prevalent cases numbered approximately three million—and this rose to more than six million cases in 2017 [ 65 ]. While lifestyle factors have been implicated in the upsurge in the rates of pancreatitis [ 66 ], adequate case reports and access to quality data may be partly responsible for this notable rise.…”

Excess Body Weight and Pancreatic Disease

“…Just as EBW has been a constantly growing health-care issue, also the global burden of pancreatic diseases has increased over the past decades [4, 5]. In this context, acute pancreatitis (AP) presents the most common pancreatic disease, while pancreatic cancer (PC) is the most lethal one [6].…”